Navigation Links
New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder

r placebo (n=118). Significantly more patients in the desvenlafaxine succinate group responded to treatment compared with the placebo group (51 percent vs. 32 percent, respectively) at the final study evaluation. When individual items from the HAM-D17 were analyzed, desvenlafaxine succinate patients experienced a statistically significant improvement in depressed mood, psychic anxiety, general somatic symptoms and suicidal thoughts. Treatment-emergent adverse events reported in this study were consistent with the SNRI class and included nausea, dry mouth, insomnia, somnolence, sweating, anorexia (loss of appetite), tremor and impotence.

About Desvenlafaxine

Desvenlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) studied as a potential treatment for adult men and women with MDD. Wyeth submitted a New Drug Application (NDA) for MDD on December 22, 2005. The Company also has filed an NDA for vasomotor symptoms (VMS) associated with menopause and expects a U.S. Food and Drug Administration (FDA) action letter in the third quarter of 2007. If approved, desvenlafaxine will be the first and only non-hormonal medicine for the treatment of VMS associated with menopause. Wyeth is a leader in both neuroscience and women's health care.

Wyeth discovered and developed the first SNRI approved by the FDA, which currently is the most widely used antidepressant in the world. Desvenlafaxine represents Wyeth's latest efforts and continued commitment to developing therapies to help improve the lives of patients suffering from mental health disorders.

According to a large depression trial funded by the National Institute of Mental Health, only 28 percent of patients with depression achieved remission with initial antidepressant treatment. This leaves a large percentage of patients still suffering from depression. Clearly, additional medicines are needed for treating MDD.

About Antidepressants

Antidepressants increased the risk of s
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:7/25/2014)... , July 25, 2014 Research and ... "Global Ophthalmic Diagnostic Devices Market 2014-2018" report to ... About Ophthalmic Diagnostic Device ... to identify a defect or deficiency in the human ... ophthalmic disorders such as presbyopia, cataracts, glaucoma, retinal disorders, ...
(Date:7/25/2014)... 2014  IDEXX Laboratories, Inc. (NASDAQ: IDXX ... of 2014 increased 11% versus the prior year period ... the second quarter of 2014 versus the prior year ... distributor inventory 2 . Earnings per diluted share ("EPS") ... from the prior year period to $1.10."In the second ...
(Date:7/25/2014)... Pa. , July 25, 2014  AMETEK, Inc. ... of Kurtis L. Goos as Vice President ... Materials, Interconnects and Packaging (EMIP) Division. "I ... extensive general management and business development experience, especially in ... make important contributions to the continued growth and success ...
Breaking Medicine Technology:Global Ophthalmic Diagnostic Devices Market 2014-2018: Key Vendors are Alcon, Carl Zeiss, Haag-Streit and Topcon 2IDEXX Laboratories Announces Second Quarter Results 2IDEXX Laboratories Announces Second Quarter Results 3IDEXX Laboratories Announces Second Quarter Results 4IDEXX Laboratories Announces Second Quarter Results 5IDEXX Laboratories Announces Second Quarter Results 6IDEXX Laboratories Announces Second Quarter Results 7IDEXX Laboratories Announces Second Quarter Results 8IDEXX Laboratories Announces Second Quarter Results 9IDEXX Laboratories Announces Second Quarter Results 10IDEXX Laboratories Announces Second Quarter Results 11IDEXX Laboratories Announces Second Quarter Results 12IDEXX Laboratories Announces Second Quarter Results 13IDEXX Laboratories Announces Second Quarter Results 14IDEXX Laboratories Announces Second Quarter Results 15IDEXX Laboratories Announces Second Quarter Results 16IDEXX Laboratories Announces Second Quarter Results 17IDEXX Laboratories Announces Second Quarter Results 18IDEXX Laboratories Announces Second Quarter Results 19IDEXX Laboratories Announces Second Quarter Results 20IDEXX Laboratories Announces Second Quarter Results 21IDEXX Laboratories Announces Second Quarter Results 22IDEXX Laboratories Announces Second Quarter Results 23IDEXX Laboratories Announces Second Quarter Results 24IDEXX Laboratories Announces Second Quarter Results 25IDEXX Laboratories Announces Second Quarter Results 26IDEXX Laboratories Announces Second Quarter Results 27IDEXX Laboratories Announces Second Quarter Results 28IDEXX Laboratories Announces Second Quarter Results 29IDEXX Laboratories Announces Second Quarter Results 30IDEXX Laboratories Announces Second Quarter Results 31IDEXX Laboratories Announces Second Quarter Results 32IDEXX Laboratories Announces Second Quarter Results 33IDEXX Laboratories Announces Second Quarter Results 34AMETEK Names Kurtis L. Goos, Vice President & General Manager, Engineered Medical Components 2
... Nov. 13 Warner Chilcott plc (Nasdaq: WCRX ... its ordinary shares by certain selling shareholders. The ... DLJ Merchant Banking, J.P. Morgan Partners (advised by CCMP ... institutional investors and members of the Company,s senior management. ...
... HAIKOU, China, Nov. 13 /PRNewswire-Asia-FirstCall/ -- Kun Run,Biotechnology, Inc. (the ... company in China that focuses on manufacturing and,sales of peptides ... quarter ended September 30, 2009. , , ... 65% from the third quarter of 2008 to a quarterly, ...
Cached Medicine Technology:Warner Chilcott Announces Secondary Equity Offering 2Warner Chilcott Announces Secondary Equity Offering 3Warner Chilcott Announces Secondary Equity Offering 4Kun Run Biotechnology, Inc. Announces Third Quarter 2009 Results 2Kun Run Biotechnology, Inc. Announces Third Quarter 2009 Results 3Kun Run Biotechnology, Inc. Announces Third Quarter 2009 Results 4Kun Run Biotechnology, Inc. Announces Third Quarter 2009 Results 5Kun Run Biotechnology, Inc. Announces Third Quarter 2009 Results 6Kun Run Biotechnology, Inc. Announces Third Quarter 2009 Results 7
(Date:7/25/2014)... Mateo, CA (PRWEB) July 25, 2014 ... an upcoming episode of Innovations with Ed Begley Jr, ... and show times TBA. , For more than four ... the Bay Area community through its residential alcohol and ... will educate on Project Ninety's humble idea and how ...
(Date:7/25/2014)... July 25, 2014 Home Care Assistance ... provider of non-medical, in-home senior care, is weighing in ... be supporting senior-led projects in Alberta through their New ... for Seniors Program is a federal grants and contributions ... who make a difference in the lives of others ...
(Date:7/25/2014)... 25, 2014 The Futon Shop ... Futon Sale. The Futon Shop has been around since 1976 ... has grown from a few handmade futon mattresses a month, ... of futon mattresses. , The Futon Shop futon mattresses ... the desire to sleep on natural fibers was a growing ...
(Date:7/25/2014)... ZeptoMetrix™ Corporation (ZMC), an industry ... products and services for infectious disease diagnostic development, ... RP Multimarker Controls - MDZ001 . , ... CE marked, unassayed external run control intended for ... RP Multimarker Controls - MDZ001 has been specifically ...
(Date:7/25/2014)... NC (PRWEB) July 25, 2014 Researchers at ... the results of a study indicating that a man-made material ... mesothelioma among workers exposed to asbestos. Surviving Mesothelioma has just ... to read it now. , The French scientists ... developed mesothelioma between 1987 and 2006. One group of ...
Breaking Medicine News(10 mins):Health News:Project Ninety to be Featured on Innovations with Ed Begley, Jr. 2Health News:Project Ninety to be Featured on Innovations with Ed Begley, Jr. 3Health News:Home Care Assistance – Halton/Peel Region Weighs in on Alberta Communities Receiving Funding to Support Seniors and Senior Caregivers 2Health News:Home Care Assistance – Halton/Peel Region Weighs in on Alberta Communities Receiving Funding to Support Seniors and Senior Caregivers 3Health News:Organic Mattress Manufacturer Celebrates 38 Years Of Being In Business 2Health News:Organic Mattress Manufacturer Celebrates 38 Years Of Being In Business 3Health News:ZeptoMetrix™ Corporation (ZMC) Releases FDA Class 1 Exempt, IVD and CE Labeled NATtrol™ RP Multimarker Controls 2Health News:New Study Shows Mesothelioma Risk is Higher in Workers Exposed to Man-Made Insulator, According to Surviving Mesothelioma 2Health News:New Study Shows Mesothelioma Risk is Higher in Workers Exposed to Man-Made Insulator, According to Surviving Mesothelioma 3
... in Central Pennsylvania Earn Designation, CAMP HILL, ... to announce the recognition of Penn State Hershey ... Centers for Complex and Rare,Cancers., Complex and ... cases each year, making it difficult for patients ...
... Alexion,Pharmaceuticals, Inc. (Nasdaq: ALXN ) today announced that ... present at,two upcoming investor conferences, one sponsored by Cowen ... Bell will present at the Cowen and Company 27th ... on Tuesday, March 18, 2008.,Dr. Bell will also present ...
... Celebration and ... NEW YORK, March 11 Autism Speaks, the world,s ... to mark the inaugural celebration of World Autism Awareness ... disorder,affecting millions of individuals and families around the world. ...
... Children,s Hospitals to Deliver Specialized Pediatric Patient Education at ... ... BETHESDA, Md. and WILMINGTON, Del., March 11 ,GetWellNetwork, Inc., ... the largest provider of online pediatric health,information, today announced a ...
... fight against increasing obesity, according to internationally regarded expert ... , Its becoming well known that there are high ... has significant consequences for chronic diseases, both physical and ... known is that not only blood vessels to the ...
... Appointment broadens reach of expanding care and care ... the,Brentwood, Tenn.-based provider of care management for the ... care policy expert,Stuart Altman has been appointed to ... expert care and care management company focused on,improving ...
Cached Medicine News:Health News:Highmark Blue Shield and National Association Name Area Hospitals as Blue Distinction Centers for Complex and Rare Cancers 2Health News:Highmark Blue Shield and National Association Name Area Hospitals as Blue Distinction Centers for Complex and Rare Cancers 3Health News:Autism Speaks to Celebrate World Autism Awareness Day with Day-Long Series of International Events on April 2 2Health News:Autism Speaks to Celebrate World Autism Awareness Day with Day-Long Series of International Events on April 2 3Health News:Autism Speaks to Celebrate World Autism Awareness Day with Day-Long Series of International Events on April 2 4Health News:GetWellNetwork and KidsHealth Partner to Empower Pediatric Patients and Their Families 2Health News:GetWellNetwork and KidsHealth Partner to Empower Pediatric Patients and Their Families 3Health News:GetWellNetwork and KidsHealth Partner to Empower Pediatric Patients and Their Families 4Health News:Stuart Altman, Ph.D. Joins INSPIRIS Board of Directors 2Health News:Stuart Altman, Ph.D. Joins INSPIRIS Board of Directors 3
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Medicine Products: